Chugai Pharmaceutical Co. Ltd. (CHGCY)
OTC
Real-time Data
01:30 PM
Day's Range
21.9352 wk Range
20.27Overview - CHGCY - Chugai Pharmaceutical Co. Ltd.
Key Statistics
Valuation
Enterprise Value
-5.60B
P/E (Trailing)
‪24.38‬
Price / Sales (TTM)
‪0.05‬
Price / Book
‪5.73‬
EV / EBITDA
‪-1.31‬
Profitability
Profit Margin
‪35.10%‬
Operating Margin
‪47.09%‬
Return on Assets
‪17.05%‬
Return on Equity
‪23.49%‬
Ownership
Shares Outstanding
1.64B
Float
1.27B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.06%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪22.42‬
200-Day Avg
‪25.87‬
Dividends
Payout Ratio
‪50.23%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CHGCY - Chugai Pharmaceutical Co. Ltd.
Peers - CHGCY - Chugai Pharmaceutical Co. Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- CHGCYOTCChugai Pharmaceutical Co. Ltd.73.03BMarket Cap+4.25%52-week change23.88P/E (Trailing)‪35.10%‬Profit Margin
- RHHVFOTCRoche Holding AG372.60BMarket Cap+32.02%52-week change24.39P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSEFOTCNovartis AG299.57BMarket Cap+22.65%52-week change23.81P/E (Trailing)‪22.50%‬Profit Margin
- NONOFOTCNovo Nordisk A/S206.51BMarket Cap-22.13%52-week change11.42P/E (Trailing)‪35.34%‬Profit Margin
- GLAXFOTCGSK plc101.54BMarket Cap+21.96%52-week change15.94P/E (Trailing)‪14.52%‬Profit Margin
- BAYZFOTCBayer AG55.43BMarket Cap+41.82%52-week change28.11P/E (Trailing)‪-3.83%‬Profit Margin
- BAYRYOTCBayer AG Sponsored ADR55.13BMarket Cap+42.18%52-week change28.38P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - CHGCY - Chugai Pharmaceutical Co. Ltd.
About
Chugai Pharmaceutical Co. Ltd. is a prominent player in the biotechnology and pharmaceutical industry, renowned for its commitment to innovative drug development and personalized healthcare solutions. The Tokyo-based company, founded in 1925, has established itself as a leader in the field of oncology, immunology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
